CCI clears Sun-Ranbaxy deal with riders; asks to divest 7 products
The approval, which comes within days of clearance from theFIPB, for the deal that was announced in April and would create create India's largest and world's fifth biggest drug-maker.
Dec 08, 2014, 18:23 PM IST
CCI approves Sun Pharma-Ranbaxy deal; creates India's largest pharma co
However, the approval did not come without its share of conditions as the CCI asked the two companies to divest some products as not to affect fair competition in the market.
Dec 08, 2014, 17:49 PM IST
AstraZeneca, Ranbaxy prevail in Nexium antitrust trial
The US Federal Trade Commission estimates that pay-for-delay deals, in which a branded drugmaker pays a generic rival to stay off the market, cost consumers $3.5 billion each year.
Dec 06, 2014, 08:43 AM IST
After US, Germany bans export of Ranbaxy's Dewas plant drugs
In fresh overseas troubles, drugmaker Ranbaxy has been barred from exporting certain antibiotics produced at its Dewas plant to Germany for non-compliance to 'good manufacturing practice' norms.
Dec 03, 2014, 21:18 PM IST
CCI suggests changes to Sun Pharma-Ranbaxy deal
The deal, which CCI has prima-facie found to be in violation of competition norms, was inked in April this year and has been awaiting clearance from the competition watchdog since then.
Dec 01, 2014, 15:56 PM IST
US court refuses Ranbaxy appeal to block ANDA nod for 2 drugs
Drug firm Ranbaxy Laboratories on Wednesday said the DC Federal Court in the US has not granted the company temporary restraining order to block the US health regulator from approving other ANDAs for generic versions of digestive disorder medicine Nexium and anti-viral Valcyte.
Nov 26, 2014, 14:26 PM IST
Ranbaxy sues FDA over revoking approvals for Nexium, Valcyte copies
Ranbaxy Laboratories Ltd has sued the U.S. Food and Drug Administration (FDA) for revoking approvals granted to the firm to launch copies of two drugs including AstraZeneca Plc`s heartburn pill Nexium, court documents showed.
Nov 18, 2014, 15:35 PM IST
Ranbaxy loses 6 months exclusivity for generic antiviral drug
Drug firm Ranbaxy Laboratories today said the US health regulator has revoked its tentative approvals for its generic anti-viral drug and stomach and esophagus problems treatment tablets.
Nov 06, 2014, 20:12 PM IST
Ranbaxy posts Q2 net profit of Rs 477.75 cr
Drug firm Ranbaxy Laboratories Tuesday reported a consolidated net profit of Rs 477.75 crore for the quarter ended September 30, 2014 on account of robust sales.
Oct 28, 2014, 14:34 PM IST
Pfizer, Ranbaxy win dismissal of lawsuit over generic Lipitor
Pfizer Inc and India`s Ranbaxy Laboratories Ltd on Friday won dismissal of a U.S. antitrust lawsuit accusing them of conspiring to delay sales of generic versions of the best-selling cholesterol drug Lipitor.
Sep 13, 2014, 11:08 AM IST
Sun Pharma falls 6% on reports of FDA inspection at Halol unit
Sun Pharmaceutical Industries on Thursday slumped as much as 6 percent, heading towards its biggest single day fall since March 16, 2012.
Sep 11, 2014, 11:10 AM IST
CCI says Sun-Ranbaxy deal may hit competition; seeks comments
In the first-ever public scrutiny of an M&A deal in India, fair trade watchdog CCI on Thursday invited comments from all stakeholders, including general public, on finer details of USD 4-billion merger of Ranbaxy Labs into rival Sun Pharmaceuticals.
Sep 04, 2014, 12:13 PM IST
Sun-Ranbaxy deal: CCI raises concerns about molecules market
Sun Pharma and Ranbaxy had announced a USD 4-billion deal that would create one of the top five largest speciality generics company in the world.
Aug 29, 2014, 13:51 PM IST
Sun Pharma-Ranbaxy deal comes under CCI scanner
CCI would take a final view on the deal after receiving details from them and could seek more information if it is not satisfied with the responses.
Aug 08, 2014, 12:34 PM IST
Ranbaxy Q1 net loss narrows to Rs 185.92 cr
The company had posted a net loss of Rs 524.24 crore for the corresponding period of the previous fiscal, Ranbaxy Laboratories said in a statement.
Jul 29, 2014, 17:59 PM IST
Management rejig at Ranbaxy; Arno Gessner replaces Dale Adkisson
Meanwhile the company has made Alexander Gebauer as its new head of global research and development.
Jul 26, 2014, 11:16 AM IST
Almost 450 stocks hit 52-week highs on BSE
A total of 447 stocks touched their 52-week highs on the BSE, including Lupin, Ranbaxy Lab, Strides Arcolab, Sun Pharma, Tata Motors, Tech Mahindra and TVS Motor.
Jul 03, 2014, 19:05 PM IST
Ranbaxy gets FDA approval for Novartis' Diovan generic
Ranbaxy will be the first rival drugmaker to launch a copy of Diovan in the United States and will be entitled to six months of exclusivity to sell it.
Jun 27, 2014, 09:39 AM IST
